Business
Grant of Options
Judges Scientific plc has granted options over 81,600 new ordinary shares at an exercise price of £52.00 per share, reflecting the closing mid-price on 27 January 2026. These options are part of the 2025 share option schemes and are awarded to executive directors, including Tim Prestidge, Brad Ormsby, and Ian Wilcock, as incentives and in recognition of Tim Prestidge's appointment as Chief Executive. The options vest after three years, contingent on achieving 5% compound growth in adjusted earnings per share and continued employment. Disclaimer*
About this update from Judges Scientific Plc
[{"type":"text","content":"\n\n29 January 2026\n \nJudges Scientific plc\n(\"Judges Scientific\" or the \"Company\")\n \nGrant of Options\n \nJudges Scientific announces that it has issued options under the 2025 share option schemes over 81,600 new ordinary shares of 5 pence each in the Company (\"Ordinary Shares\") at an exercise price per share of £52.00, being the closing mid-price on 27 January 2026.\n \nThe Remuneration Committee have awarded, both in recognition of the appointment of Tim Prestidge to Chief Executive on 9 February 2026 and in accordance with its policy of annual awards of share options to retain and incentivise the Executive Directors, the share options as shown in the table below. Vesting of these options after three years is subject to the achievement of 5% compound growth in adjusted earnings per share over the vesting period, and to continued employment.\n \n\n\n\n\nDirector\n\n\nNumber of options\n\n\nOption Scheme\n\n\nVesting date\n\n\nExpiry date\n\n\n\n\nTim Prestidge\n\n\n1,153\n\n\nApproved\n\n\n28/01/2029\n\n\n27/01/2036\n\n\n\n\nTim Prestidge\n\n\n58,847\n\n\nUnapproved\n\n\n28/01/2029\n\n\n27/01/2036\n\n\n\n\nBrad Ormsby\n\n\n1,153\n\n\nApproved\n\n\n28/01/2029\n\n\n27/01/2036\n\n\n\n\nBrad Ormsby\n\n\n9,647\n\n\nUnapproved\n\n\n28/01/2029\n\n\n27/01/2036\n\n\n\n\nIan Wilcock\n\n\n576\n\n\nApproved\n\n\n28/01/2029\n\n\n27/01/2036\n\n\n\n\nIan Wilcock\n\n\n10,224\n\n\nUnapproved\n\n\n28/01/2029\n\n\n27/01/2036\n\n\n\n\n \n \nFor further information please contact: \n \n\n\n\n\nJudges Scientific plc\nDavid Cicurel, CEO\nBrad Ormsby, CFO\nTel: +44 (0) 20 3829 6970\n \n \n\n\nShore Capital (Nominated Adviser & Joint Broker)\nStephane Auton\nHarry Davies-Ball\nTel: +44 (0) 20 7408 4090\n \n\n\n\n\n\n\n\nPanmure Liberum (Joint Broker)\nEdward Mansfield\nWilliam King\nTel : +44 (0) 20 3100 2222\n \n \n\n\nInvestec Bank plc (Joint Broker)\nVirginia Bull\nCarlton Nelson\nTel: +44 (0) 20 7597 4000\n\n\n\n\n\n\n\nAlma (Financial Public Relations)\nSam Modlin\nRebecca Sanders-Hewett\nJoe Pederzolli\nSarah Peters\nTel: +44 (0) 20 3405 0205\[email protected]\n\n\n\n\n\n\n\n\n\n\n \nNotes to editors:\nJudges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific i...